Image Results

Sandostatin And Carcinoid And Case Study Pages on BioPortfolio:

BioPortfolio - Malignant Carcinoid Syndrome
Malignant Carcinoid Syndrome - BioPortfolio - Indepth. ... malignant carcinoid syndrome | sandostatin and carcinoid and case study | maligant carcinoid | . ...
http://www.bioportfolio.com/indepth/Malignant_Carcinoid_Synd...

Results from other life science and pharmaceutical sites:

Sandostatin® LAR Depot | Industry information for Sandostatin® LAR ...
Recognizing the Signs & Symptoms of Carcinoid Syndrome: A Case Study ... As with immediate release Sandostatin® Injection, the most frequently reported ...
http://www.medscape.com/infosite/sandostatin/article-3...

Carcinoid Syndrome: Carcinoid Tumors: Merck Manual Professional
Carcinoid syndrome develops in some people with carcinoid tumors and is characterized by cutaneous flushing, abdominal cramps, and diarrhea. ....
Numerous studies have suggested good results with octreotide Some Trade Names
SANDOSTATIN ... Case reports indicate that tamoxifen Some Trade Names NOLVADEX
...
http://www.merck.com/mmpe/sec12/ch161/ch161b.html...

Sandostatin® LAR Depot | Industry information for Sandostatin® LAR ...
Diarrhea and flushing: Are you thinking carcinoid syndrome? Read a case study ». Important Safety Information. About Sandostatin® LAR Depot ...
http://www.medscape.com/infosite/sandostatin...

Breast metastasis of ilial carcinoid tumor: Case report and ...
We report a case of unilateral breast metastasis from carcinoid tumor of the ... The patient was initiated on subcutaneous octreotide (Sandostatin) at a dose
.... and electron microscopic study in a case of carcinoid of the male breast.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1481627/...

Sandostatin® LAR Depot | Industry information for Sandostatin® LAR ...
Effective Symptom Control in Carcinoid Syndrome With Sandostatin® LAR Depot ... The Sandostatin 20-Year Heritage · Case Study in Recognizing Carcinoid ...
http://www.medscape.com/infosite/sandostatin/article-2...

Acromegaly caused by a growth hormone-releasing hormone-secreting ...
This case report illustrates the importance of including this rare clinical syndrome in ... Endocrinological studies demonstrated a growth hormone level of
more than 100 ng/ml ... Therapy with long-acting repeatable octreotide (
Sandostatin LAR; Novartis AG, ... to further control the acromegaly and
carcinoid tumor. ...
http://www.ncbi.nlm.nih.gov/pubmed/12015856...

Sandostatin® LAR Depot | Industry information for Sandostatin® LAR ...
The NCCN recommends Sandostatin® LAR Depot as first-line medical therapy ... The Sandostatin 20-Year Heritage · Case Study in Recognizing Carcinoid Syndrome ...
http://www.medscape.com/infosite/sandostatin/article-1...

Distinguishing features of idiopathic flushing and carcinoid syndrome.
Flushing in carcinoid patients responds uniformly to octreotide (Sandostatin), but only one third ... Case Reports; Comparative Study; Research Support, Non-
U.S. Gov't ... Malignant Carcinoid Syndrome/complications; Malignant Carcinoid
...
http://www.ncbi.nlm.nih.gov/pubmed/2461688...

Sandostatin® LAR Depot | Industry information for Sandostatin® LAR ...
Case Study in Recognizing Carcinoid Syndrome ... As with immediate release Sandostatin® Injection, the most frequently reported drug-related adverse events
...
http://www.medscape.com/infosite/sandostatin/article-5...

Guidelines for the management of gastroenteropancreatic ...
A survey by the Oncology Study Section of the Italian Society of ..... Kotoh K, Nawata H. Primary hepatic carcinoid tumor: case report and review of 53 cases.
... Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.